Details and loose ends

Quote

Anonymous

Guest
Checking in to see where others stand.

Have your expense reports been approved? Mine hasn't.
Have you received your fedex? Not me.
Gotten a call from anyone about equipment? Nope
Seen any final numbers? Nothing.

Breathing and moving on. Yep.
 










































I got my fedex. My big question is, where the heck is the information for sending our signed cooy back? I don't see an address, email, fax #, or self addressed envelope. Also, no clear date for when it has to be returned. Section 13 is about as clear as mud.
 






Anonymous said:
Don't do that you won't get your package until they get the samples and equipment!
Click to expand...

OK Aaron.


WTF They decide when these idiots get around to us. Since the company is so F'ing cheap (its a 60 day WARN we are getting, theses no benevolence here, its law) they will probably hire 2 people to get there arses around to 170 people. Maybe you see them for Hannaukah


Let the ear whigs and spiders take hold.
 






Anonymous said:
I got my fedex. My big question is, where the heck is the information for sending our signed cooy back? I don't see an address, email, fax #, or self addressed envelope. Also, no clear date for when it has to be returned. Section 13 is about as clear as mud.
Click to expand...

Call the home office and get the email address for Donna or Christine. Remember that the home office is @amarincorp.com.
 












from what I see.....

HR had NO notice this was going to happen untill the e-mail went out

Amarin didn't contract for sample return and computer return untill the end of last week. (part of why I think HR was blindsided too)

RSD's had NO notice this was going on. None!

Someone at the top walked into the HQ on Tuesday and paniced!

Question is, did he receive work from FDA - no approval and go ahead, sue us for breaking the agreement. See you in court skippy or is he just that stupid to abandon the drug and hope for a buyout.

Just stupid.

And talk about stupid, who asked for CHD indication anyway? Someone did or the FDA would not have posed that question. Seriously folks, if the FDA made-up the question for the ADCOM don't you think someone from Amarin would have said whooo, time out. Thats not what we asked for.

Hell AB lied directly to us when he said nope, not the indication we asked for.... Bull Crap
 






Anonymous said:
from what I see.....

HR had NO notice this was going to happen untill the e-mail went out

Amarin didn't contract for sample return and computer return untill the end of last week. (part of why I think HR was blindsided too)

RSD's had NO notice this was going on. None!

Someone at the top walked into the HQ on Tuesday and paniced!

Question is, did he receive work from FDA - no approval and go ahead, sue us for breaking the agreement. See you in court skippy or is he just that stupid to abandon the drug and hope for a buyout.

Just stupid.

And talk about stupid, who asked for CHD indication anyway? Someone did or the FDA would not have posed that question. Seriously folks, if the FDA made-up the question for the ADCOM don't you think someone from Amarin would have said whooo, time out. Thats not what we asked for.

Hell AB lied directly to us when he said nope, not the indication we asked for.... Bull Crap
Click to expand...

1. The company was going to go bankrupt (and still will no matter what, this is just a strategic move to get everybody closed out. The other 50% will be gone in January) so they shot for the moon and tried to get CHD within the label just because the REDUCE-IT Trial was occuring

2. If the company would not have put so much effort into selling itself last fall and actually did pre launch MARKETING for Vascepa and approached it the right way, we would have been much better off. This drug rolled out in january with 2% physician awareness. 2%!!!!! It was doomed to fail from the beginning and most of us would have never signed on had we known this.

3. GSK sat back, read our playbook, and choked off what little momentum every chance they could. Notice how every doc was askinh about "outcomes" the last few months? Their selling line was "we don't have outcomes, they don't either and we lower trigs more. Why would you use Vascepa?" I tried bringing this up on a training call before POA with the marketing team and I was lambasted and was in the process of getting run out of the company just for forwarding this feedback up to HQ. I am 100% certain the CEO heard about it, because the way I was being dealt with had his stubby, fat fingerprints all over it

4. The faster we can all put this behind us, the better. Some friendly advice: Fully vet the next company you apply to work for. Read some financial summaries. Ask a rep who works for them. Ask some physician friends what THEY think of the company. This will tell you a LOT. This is a learning experience and we are all much better off now. One last thing: NEVER work for a company that only has one product ever again.
 






Here is the question the advisory board members were voting on. It is posted on the FDA website:

Taking into account the described efficacy and safety data for Vascepa, do you believe
that its effects on the described lipid/lipoprotein parameters are sufficient to grant approval
for co-administration with statin therapy for the treatment of patients with mixed
dyslipidemia and CHD or CHD risk equivalent prior to the completion of REDUCE-IT?
Please provide the rationale underlying your recommendation.
 






Anonymous said:
Here is the question the advisory board members were voting on. It is posted on the FDA website:

Taking into account the described efficacy and safety data for Vascepa, do you believe
that its effects on the described lipid/lipoprotein parameters are sufficient to grant approval
for co-administration with statin therapy for the treatment of patients with mixed
dyslipidemia and CHD or CHD risk equivalent prior to the completion of REDUCE-IT?
Please provide the rationale underlying your recommendation.
Click to expand...

They WANTED an excuse to fold the company up and close up shop. It was on its way to insolvency.
What a ridiculous thing to try and go for.
ANCHOR would have resulted in bankruptcy as well, too much of a late start to the game. This whole ordeal was a buy-out ploy gone horribly wrong after nobody bought the company at the end of 2012.
 






Anonymous said:
from what I see.....

HR had NO notice this was going to happen untill the e-mail went out

Amarin didn't contract for sample return and computer return untill the end of last week. (part of why I think HR was blindsided too)

RSD's had NO notice this was going on. None!

Someone at the top walked into the HQ on Tuesday and paniced!

Question is, did he receive work from FDA - no approval and go ahead, sue us for breaking the agreement. See you in court skippy or is he just that stupid to abandon the drug and hope for a buyout.

Just stupid.

And talk about stupid, who asked for CHD indication anyway? Someone did or the FDA would not have posed that question. Seriously folks, if the FDA made-up the question for the ADCOM don't you think someone from Amarin would have said whooo, time out. Thats not what we asked for.

Hell AB lied directly to us when he said nope, not the indication we asked for.... Bull Crap
Click to expand...

HR, the 2 RSDs and Aaron had a meeting the day after the adcom in our home office to put in place a plan moving forward. So you can see HR and RSDs (at least two) knew everything five days earlier.
 






This Aaron or AB mentioned, is that Berg? Former GSKer from the Avandia days. Just wondering if it is the same guy? Based on what I am reading, it very could be! Once a snake, always a snake.
 
























Top Bottom
Back
Quote